Company Filing History:
2 out of 5,076 
1 out of 155 
1 out of 237 Years Active: 2018-2025
Title: Olivier Goureau: Innovator in Retinal Cell Research
Introduction
Olivier Goureau is a prominent inventor based in Paris, France. He has made significant contributions to the field of retinal cell research, particularly in the area of cell culture and amplification of retinal progenitor cells. With a total of 2 patents, Goureau's work is paving the way for advancements in regenerative medicine.
Latest Patents
Goureau's latest patents include innovative methods and compositions for the efficient amplification of retinal progenitor cells. One of his notable patents describes a defined cell culture medium that facilitates the expansion of human retinal progenitors. This medium comprises a nutrient solution, a SHH-pathway activator, and a GSK3 inhibitor. The patent outlines the use of this defined cell culture medium for expanding retinal progenitors and details an in vitro method for culturing these cells effectively.
Another significant patent focuses on methods for obtaining retinal progenitors, retinal pigmented epithelial cells, and neural retinal cells. This method involves placing an adherent culture of human pluripotent stem cells in a pro-neural medium and maintaining the culture until pigmented cells or neuroepithelial-like structures appear. Additional steps can be taken to derive retinal pigmented epithelial cells and precursors of the neural retina.
Career Highlights
Olivier Goureau has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Pierre et Marie Curie (Paris 6). His research has been instrumental in advancing our understanding of retinal cell biology and potential therapeutic applications.
Collaborations
Goureau has collaborated with notable colleagues, including Sacha Reichman and Jose-Alain Sahel. These partnerships have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Olivier Goureau's work in retinal cell research exemplifies the impact of innovation in the field of regenerative medicine. His patents and collaborations highlight his commitment to advancing scientific knowledge and improving therapeutic strategies for retinal diseases.